DRKS00015670已完成未知
Clinical Trial according to §23b MPG on Performance, safety and clinical benefit of hysan Nasensalbe (HYNASA-2018) - HYNASA-2018
RSAPHARM Arzneimittel GmbH0 个研究点目标入组 100 人开始时间: 2018年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 12 Years 至 one（—）
- 性别
- All
入选标准
- •Adults and children above 12 years
- •- Sore nose
- •- At least two symptoms must be at least assessed as mild or one symptom as strong or very strong
- •- Informed consent
排除标准
- •Current Treatment of sore nose
- •Expected non-compliance, no cooperation
- •participation in another trial within the last 4 weeks and/or contemporaneously to this Trial
研究者
相似试验
已完成
4 期
Clinical Trial (according to §23b MPG) on performance, safety and clinical benefit of hysan Pflegespray, hysan Hyaluronspray and Ocean-Spray Plus in otorhinolaryngology.dry noseDRKS00013357RSAPHARM Arzneimittel GmbH240
尚未招募
2 期
A clinical trial to evaluate the performance and safety of the wekebere system for monitoring fetal wellbeing during laborPregnancy and ChildbirthPACTR202311817720428Vilgro Africa120
招募中
3 期
on-inferiority clinical trial to compare efficacy and safety of Pembrolizumab (CinnaGen Co.) versus Keytruda® in patients with metastatic Non-Small Cell Lung Cancer (NSCLC)IRCT20150303021315N29CinnaGen company295
已完成
3 期
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant ChemotherapyBreast cancerJPRN-UMIN000021016RG Oncology1,636
进行中（未招募）
不适用
A Phase III, Randomized, Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on a Sulfonylurea in Combination With MetformiDiabetes Mellitus type 2MedDRA version: 12.1Level: LLTClassification code 10067585Term: Type 2 diabetes mellitusEUCTR2010-018318-62-HUMerck & Co., Inc.424